- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine signaling in multiple sclerosis: Lost in translation
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 24, Issue 4, Pages 432-439
Publisher
SAGE Publications
Online
2018-03-07
DOI
10.1177/1352458518763094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System
- (2017) Sabine Spath et al. IMMUNITY
- IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
- (2017) Jin Kyeong Choi et al. Frontiers in Immunology
- The role of interleukin-6 signaling in nervous tissue
- (2016) Michelle Rothaug et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF + Th17 cells
- (2016) Ilgiz A Mufazalov et al. EMBO JOURNAL
- Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
- (2016) Eva Havrdová et al. JOURNAL OF NEUROLOGY
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- Tocilizumab, MS, and NMOSD
- (2016) Ingo Kleiter et al. Multiple Sclerosis Journal
- Th9 cells in the pathogenesis of EAE and multiple sclerosis
- (2016) Wassim Elyaman et al. Seminars in Immunopathology
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- Tocilizumab, MS, and NMOSD
- (2016) Ingo Kleiter et al. Multiple Sclerosis Journal
- Daclizumab high-yield process in the treatment of relapsing–remitting multiple sclerosis
- (2016) Jana Lizrova Preiningerova et al. Therapeutic Advances in Neurological Disorders
- Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease
- (2015) Lin Sun et al. CYTOKINE
- The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
- (2015) Andrew L. Croxford et al. IMMUNITY
- Interleukin-17- and interleukin-22-secreting myelin-specific CD4+T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
- (2015) Ana Cristina Wing et al. IMMUNOLOGY
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis
- (2015) Ghasem Ghalamfarsa et al. Journal of Immunotoxicology
- The therapeutic potential of interleukin-10 in neuroimmune diseases
- (2015) A.J. Kwilasz et al. NEUROPHARMACOLOGY
- TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
- (2015) L. Probert NEUROSCIENCE
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
- (2014) Aimin Wu et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects
- (2014) Mansour Shajarian et al. IMMUNOLOGICAL INVESTIGATIONS
- Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
- (2014) I. L. Campbell et al. JOURNAL OF NEUROSCIENCE
- Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6
- (2013) Mercedes Giralt et al. GLIA
- Dual role of Response gene to complement-32 in multiple sclerosis
- (2012) Cosmin A. Tegla et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
- (2011) Roberta Brambilla et al. BRAIN
- The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination
- (2011) Volker Limmroth et al. Therapeutic Advances in Neurological Disorders
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- (2010) Amy E. Lovett-Racke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cytokine networks in multiple sclerosis: lost in translation
- (2010) Laura Codarri et al. CURRENT OPINION IN NEUROLOGY
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System
- (2008) Marco Prinz et al. IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started